Oncology

Filter

Unmet Need in 1L HR+/HER2- Advanced Breast Cancer

1 Mins

October 2025

Explore why outcomes often decline after first-line endocrine therapy in HR+/HER2- advanced breast cancer and how emerging treatments…

Unmet Need in 1L HR+/HER2- Advanced Breast Cancer

Explore why outcomes often decline after first-line endocrine therapy in HR+/HER2- advanced breast cancer and how emerging treatments…

Paradigm Shift in ESR1 Testing: Spot Resistance Earlier

Explore ESR1 mutations in HR-positive breast cancer and how early ctDNA monitoring may help delay endocrine resistance…

The latest edition of AMJ Oncology

Uncover everything you need to know from this year’s ASCO congress and beyond in our new Oncology journal, featuring the latest highlights…

AMJ Oncology is out now!

The inaugural edition of AMJ Oncology delivers insights into the future of the field with detailed coverage of the 2024 ASCO Annual Meeting.

Loading posts...